Antimicrobial Wound Dressing Market Segmentation by Product Type (Hydrofiber, Hydrogel, Foam, Hydrocolloids, Collagen, Transparent Film, Alginates, and Others); and by Application (Acute, Chronic, and Surgical Wounds) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2035
Buy Now Report ID: 2856 | Published Date: Mar 15, 2023
The global antimicrobial wound dressing market is estimated to garner a revenue of ~ USD 15 Billion by the end of 2035 by growing at a CAGR of ~8% over the forecast period, i.e., 2023 – 2035. Further, the market generated a revenue of ~ USD 7 Billion in the year 2022. The growth of the market can be attributed to the increasing sports activities across the globe causing severe sports injuries in children and adults. Sports injuries can be dangerous for the future of an athlete and if immediate aid is not provided, some injuries may result in death. For instance, it was projected that approximately 3 million children below 14 receive serious sports injuries during recreational activities every year in United States.
The global antimicrobial wound dressing market is projected to thrive on account of the growing advancements in wound dressing technology, along with the rising concern amongst individuals for the threatening conditions caused by skin and soft tissue infections (SSTIs) over the forecast period. A small cut or an incision during minimally invasive or invasive surgical procedures requires dressing the wound for its proper treatment. Improper wound dressing results in severe complications of the wound and raises the likelihood of SSTIs. SSTIs result from the invasion of microbes in the skin. Owing to the antiseptic properties of antimicrobial wound dressings, antimicrobials help to lower the SSTIs during wound care. On the other hand, researchers in the healthcare industry are continuously researching advanced technologies that can increase the effectiveness of the wound-healing process. Such factors are anticipated to promote the growth of the global antimicrobial wound dressing market during the forecast period.
|
Base Year |
2022 |
|
Forecast Year |
2023-2035 |
|
CAGR |
~8% |
|
Base Year Market Size (2022) |
~ USD 7 Billion |
|
Forecast Year Market Size (2035) |
~ USD 15 Billion |
|
Regional Scope |
|
Growth Drivers
Growing Prevalence of Diabetes – diabetes is known to interfere with wound healing. This situation is caused by the involvement of immune, neuropathic, biochemical, and vascular components. Wounds heal at a very slow rate where blood vessels become stiffer and reduce tissue oxygenation. For instance, in 2021, more than 500 million people were noticed to be living with diabetes across the globe.
Rising Cases of Surgical Site Infection (SSI) – higher prevalence of surgical site infection is also observed to hike the demand for antimicrobial wound dressing over the forecast period across the globe. For instance, it was estimated that in the United States, nearly USD 10 billion are cost by surgical site infection every year.
Increasing Instances of Traumatic Wounds – traumatic wounds refer to sudden injuries such as a gunshot wound and skinned knees. These wounds also include burns, abrasions, bites, skin tears, and others. Such wounds can be chronic wounds needing constant care. For instance, around 1 million people get traumatic injuries in the USA every year, 80,000 experience long-term disability, around 200,00 people are hospitalized and approximately 40,000 die owing to TBI.
Growing Incidences of Venous Leg Ulcers – growing prevalence of venous leg ulcers is also noticed to boost the demand for antimicrobial wound dressing. For instance, it was projected that around 18 people in 1000 people aged above 80 years experience leg ulcers.
Challenges
The hard-to-heal wounds require the use of antimicrobial wound dressing as these are known to be very effective to reduce infection. But a major concern lies with the cost of the antimicrobial wound dressing, which raises the overall treatment cost of the patient. In several low- and middle-income nations, where the per capita health expenditure is comparatively very low, high treatment cost owing to high production cost is one of the major concerns. Such a factor is anticipated to hamper the overall profitability of the manufacturers of antimicrobial wound dressing, and in turn, impact negatively the market growth.
The global antimicrobial wound dressing market is segmented and analyzed for demand and supply by application to acute, chronic, and surgical wounds. Out of the three types of applications, the surgical wounds segment is estimated to gain the largest market share in the year 2035. Surgical wound infections, which are classified as superficial incisional infection, deep incisional infection, and organ/space infection by the Centers for Disease Control and Prevention (CDC), are major causes of concern among individuals globally. The increasing incidences of surgical site infections (SSIs) are raising the need for the deployment of antimicrobial wound dressing, which in turn is anticipated to drive the growth of the segment during the forecast period. As of 2021, around 100,000 cases of site infection were found across the globe. Hence, such a higher prevalence of surgical site infections (SSIs) worldwide is projected to escalate the growth of the segment over the forecast period.
The global antimicrobial wound dressing market is also segmented and analyzed for demand and supply by product type into hydrofiber, hydrogel, foam, hydrocolloids, collagen, transparent film, alginates, and others. Amongst these segments, the hydrofiber segment is expected to garner a significant share in the year 2035. Hydrofibers are used to manage wounds and injuries such as Venous, oncology wounds, traumatic wounds, surgical wounds, diabetic ulcers surgical wounds, and others. Wounds can be severe if the person who acquires them is living with obesity, advanced age, hypovolemia, malnutrition, and has a habit of smoking and steroid. Hydrofibers are non-woven ribbon dressing that is soaked in sodium carboxymethylcellulose. Also, hydrofiber is a soft material that can transform itself into a gel when it comes in contact with any wound fluid.
Our in-depth analysis of the global antimicrobial wound dressing market includes the following segments:
|
By Product Type |
|
|
By Application |
|
The North American antimicrobial wound dressing market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The growth of the market can be attributed majorly to the high prevalence of surgical wounds, coupled with the rising adoption of advanced wound dressing methodologies by healthcare specialists in hospitals and clinics. The surge in cancer cases in the region has resulted in a higher number of surgeries that results in leaving oncology wounds on the body of patients that requires immediate medical attention. For instance, it was estimated that in 2021, around 2 million new cases of cancer were diagnosed in the United States while 600,000 people died on account of cancer. Furthermore, the rising number of surgical procedures performed in the United States is also anticipated to hike the market growth over the forecast period.
The Asia Pacific antimicrobial wound dressing market, amongst the market in all the other regions, is projected to hold the second largest share during the forecast period. The growth of the market can be attributed majorly to the increasing prevalence of cancer in the region coupled with ongoing development in healthcare infrastructure and growing awareness of hygiene. For instance, in 2020, around 150 thousand new cases of cancer were diagnosed in Southeast Asia while 30 thousand cases of ovarian cancer were diagnosed in the same region. Additionally, the growing prevalence of heart diseases in the region was noticed to hike the number of heart surgeries that require antimicrobial wound dressing. Hence this factor is also anticipated to enlarge the market size in the region during the forecast period. As of 2019, cardiovascular diseases became the leading cause of death and approximately 10 million people lost their lives owing to this disease.
B. Braun Melsungen AG acquired Intermedt Medizin & Technik GmbH. The acquisition took place to accelerate the company’s growth in extracorporeal blood treatment (dialysis).
Lohmann & Rauscher GmbH & Co. KG announced that it has expanded its laboratory capacity to double its existing size in Schönau a. d. Triesting, Austria. The company also announced that it has invested in an in-house center of excellence that would focus on the development of effective antimicrobial wound dressings and biofilms.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Author Credits: Radhika Gupta, Shivam Bhutani
Ans: Rising cases of surgical site infection (SSI) and growing incidences of venous leg ulcers are the major factors driving the market growth.
Ans: The market is anticipated to attain a CAGR of ~8% over the forecast period, i.e., 2023 – 2035.
Ans: Not suitable for weepy wounds and the possibility of a loss of healthy tissue on removal is estimated to be the growth hindering factors for the market expansion.
Ans: The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Ans: The major players in the market are B. Braun Melsungen AG, Hollister Incorporated, Organogenesis Inc., Coloplast Group, Mölnlycke Health Care AB, 3M Company, ConvaTec Group PLC, Smith & Nephew plc, ConvaTec Group PLC, and others.
Ans: The company profiles are selected based on the revenues generated from segments, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by product type, application, and by region.
Ans: The surgical wounds segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Submit Your Request For Proposal (RFP)
